Read + Share
Roth A, He G, Tong H, Lin Z, et al. Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients
with paroxysmal nocturnal hemoglobinuria naive to complement inhibition. Am J Hematol 2024;99:1768-1777.
PMID: 38884175
|
 |
|
Roth A, He G, Tong H, Lin Z, et al. Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients
with paroxysmal nocturnal hemoglobinuria naive to complement inhibition. Am J Hematol 2024;99:1768-1777.
PMID: 38884175
|
|
|
|